The appropriate management of the drug reaction with eosinophilia and systemic symptoms
(DRESS) syndrome is paramount because it is associated with significant morbidity and
mortality. This syndrome shares clinical features with other dermatologic conditions,
including other severe cutaneous drug reactions, requiring the clinician to carefully examine
the proposed criteria to make the appropriate diagnosis. Once the diagnosis of DRESS
syndrome has been established, the next step in management is immediate cessation of the …